cardiomyopathy program

Cardiomyopathy(Kate Therapeutics)

ATC-0187-MYBPC3

PLN gene therapy (AAV, cardiomyopathy)

ZAK inhibitors (oral, hypertrophic cardiomyopathy)

Dilated cardiomyopathy therapy (Maze Therapeutics)

LMNA gene therapy (LMNA-related dilated cardiomyopathy)

2-mercaptobenzothiazole

C₇H₅NS₂